Non-small Cell Lung Cancer
Conditions
Brief summary
An analysis of Low-Dose Cat Scan(LDCT) Screenings for Lung Cancer completed within the St. Elizabeth system from January 2015 until December 2019. The study investigator, or designee(s), will retrospectively review patient encounters, collecting data related to LDCT referrals and completions. Data analysis will focus on the subsequent imaging, procedures, reviews at The Nodule Review Board and Lung Cancers diagnosed as a result of the LDCT.
Detailed description
This study is a single center, minimal risk, physician initiated retrospective chart review. Potential subjects will be identified using records provided by the St. Elizabeth Healthcare Thoracic Oncology and Radiology Department. Potential subjects will be screened for eligibility. Study investigator and designees will review patient electronic medical records, extracting data related to the ordering/completion of a LDCT and interventions that occurs thereafter. Collected data will focus on dates of encounters, diagnostic imaging/procedures, and treatments. Please see Appendix A for a complete list of data points. All of the data that will be collected for study purposes will be kept confidential. This will be attained by the following: First, each enrolled subject will be assigned a study specific serial number for the database. All study documents and data collection tools will be maintained with the investigative site file in a locked cabinet in a secure location maintained by the investigator. The database will not include the patient's name or hospital medical record number. No one will have access to the database but the study principal investigator and study staff designated by the principal investigator. However, study data may be reviewed by the Institutional Review Board of record, an appointed study monitor, an internal auditor for St. Elizabeth Healthcare, and necessary regulatory authorities. The security of the database will be maintained under the direction of the principal investigator. Fourth, when the study is completed, the manuscript is published, and IRB storage document requirements have been met, the file will be permanently deleted and destroyed
Interventions
None listed
Sponsors
St Elizabeth Healthcare
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients within St Elizabeth Healthcare who are referred for and/or have completed a LDCT from January 2015-February 2018 * \>=18 years of age
Exclusion criteria
• Patient undergoes subsequent imaging, procedures and/or treatment at a facility outside of St. Elizabeth where records are not available through EPIC
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Date(s) of LDCT | From patient referral for LDCT to completion of screening up to 1 year | When the patient completed the LDCT(s) |
Secondary
| Measure | Time frame |
|---|---|
| Additional Imaging caused by LDCTs | From patient referral through last radiographic image up to 6 years |
| Adverse Events caused by LDCTs | From first screen through last treatment intervention for the nodule up to 6 years |
| Additional Procedures caused by LDCTs | From evidence of concerning nodule through completion of treatment up to 6 years |
Other
| Measure | Time frame |
|---|---|
| Cancer Diagnosis | From detection of nodule through diagnostic pathology result up to 6 years |
| Stage of cancer diagnosis | From detection of nodule through diagnostic pathology result up to 6 years |
| Presentation in Tumor Board | From diagnosis of cancer through completion of treatment up to 6 years |
| Presentation in Nodule Review Board | From detection of category 4 nodule through completion of screening up to 6 years |
| Referral Date for LDCT | From identification of eligible patient through LDCT screen completion up to 1 year |
| Nodule Categories | From first LDCT through final LDCT up to 6 years |
Countries
United States
Outcome results
None listed